2024
“Recovery is about change, so you have to change everything”: Exploring the evolution of recovery capital among women in substance use disorder treatment
Jadovich E, Viera A, Edelman E, Muilenburg J, Kershaw T. “Recovery is about change, so you have to change everything”: Exploring the evolution of recovery capital among women in substance use disorder treatment. SSM - Qualitative Research In Health 2024, 5: 100422. DOI: 10.1016/j.ssmqr.2024.100422.Peer-Reviewed Original ResearchSubstance use disorder treatmentRecovery capitalSecondary qualitative analysis of dataDisorder treatmentNon-clinical interventionsCommunity capitalSubstance use disordersSecondary qualitative analysisSubstance use disorder recoveryIndirect effects of treatmentExperiences of womenEffects of treatmentSubstance use researchRecovery capital frameworkAddiction researchQualitative analysis of dataStudy time pointsThematic analysisClinical pathwayParticipants' experiencesTreatment programsDisorder recoveryWomen's experiencesCapital frameworkCapital developmentPerspectives regarding cannabis use: Results from a qualitative study of individuals engaged in substance use treatment in Georgia and Connecticut
Warnock C, Ondrusek A, Edelman E, Kershaw T, Muilenburg J. Perspectives regarding cannabis use: Results from a qualitative study of individuals engaged in substance use treatment in Georgia and Connecticut. Drug And Alcohol Dependence Reports 2024, 11: 100228. PMID: 38585142, PMCID: PMC10997993, DOI: 10.1016/j.dadr.2024.100228.Peer-Reviewed Original ResearchSubstance use disordersCannabis useQualitative study of individualsSubstance use disorder treatment outcomesTreatment-related consequencesSemi-structured interviewsSubstance use treatmentSubstance use initiationStudy of individualsImprove healthPrescription medicationsQualitative studyHealth challengesMedicine beliefsPerceived cannabisTreatment cliniciansPeer perceptionsEntering treatmentAt-riskCannabisSocial servicesStudy objectiveYoung adulthoodInterviewsHealthAvailability of substance use screening and treatment within HIV clinical sites across seven geographic regions within the IeDEA consortium
Lancaster K, Stockton M, Remch M, Wester C, Nash D, Brazier E, Adedimeji A, Finlayson R, Freeman A, Hogan B, Kasozi C, Kwobah E, Kulzer J, Merati T, Tine J, Poda A, Succi R, Twizere C, Tlali M, von Groote P, Edelman E, Parcesepe A, Consortium I. Availability of substance use screening and treatment within HIV clinical sites across seven geographic regions within the IeDEA consortium. International Journal Of Drug Policy 2024, 124: 104309. PMID: 38228025, PMCID: PMC10939808, DOI: 10.1016/j.drugpo.2023.104309.Peer-Reviewed Original ResearchAlcohol use disorder screeningHIV clinical sitesHIV care settingsProportion of clinicsSubstance use disordersAlcohol use disorderBrief interventionHIV careCare settingsClinical sitesSubstance use disorder screeningTreatment availabilityNegative impact of substance useHIV clinical settingsAvailability of screeningReferral to treatmentInternational epidemiology DatabasesHigh-income countiesImpact of substance useLower-middle-income countriesTreat alcohol use disorderUpper-middle income countriesLow-income countriesEpidemiological databasePrevalence estimates
2018
Office-Based Addiction Treatment in Primary Care Approaches That Work
Edelman EJ, Oldfield BJ, Tetrault JM. Office-Based Addiction Treatment in Primary Care Approaches That Work. Medical Clinics Of North America 2018, 102: 635-652. PMID: 29933820, DOI: 10.1016/j.mcna.2018.02.007.Peer-Reviewed Original ResearchConceptsPrimary careUse disordersPrimary care-based approachSubstance useHuman immunodeficiency virusOpioid use disorderEvidence-based treatmentsCounseling-based interventionsSubstance use disordersImmunodeficiency virusSpecialty settingsMultidisciplinary teamCare-based approachHealth disparitiesAddiction treatmentCareDisordersOptimal approachImportant settingTreatmentPharmacotherapySetting
2017
The effect of substance use disorders on the association between guideline-concordant long-term opioid therapy and all-cause mortality
Gaither J, Goulet J, Becker W, Crystal S, Edelman E, Gordon K, Kerns R, Rimland D, Skanderson M, Justice A, Fiellin D. The effect of substance use disorders on the association between guideline-concordant long-term opioid therapy and all-cause mortality. Drug And Alcohol Dependence 2017, 171: e68. DOI: 10.1016/j.drugalcdep.2016.08.196.Peer-Reviewed Original ResearchLong-term opioid therapySubstance use disordersOpioid therapyCause mortalityUse disordersTherapyMortality
2016
Potential benefits and harms of prescription opioids in HIV
Becker W, Edelman E. Potential benefits and harms of prescription opioids in HIV. 2016, 113-122. DOI: 10.1002/9781118777374.ch11.ChaptersAntiretroviral therapyPrescription opioidsPrescription drug monitoring programsTrials of opioidsUrine toxicology testingDrug monitoring programsPeripheral nervous systemSubstance use disordersNonpharmacologic modalitiesOpioid prescribingPharmacologic treatmentOpioid analgesicsPain managementPain treatmentMedication adherenceAdequate dosesAntiretroviral adherenceTreatment agreementsSafe prescribingUse disordersNervous systemOpioidsHIVPatientsSubstance use